| 國立臺灣大學 |
2010 |
Outcome in Children Bridged and Nonbridged to Cardiac Transplantation
|
林明賢; 周迺寬; 陳益祥; 紀乃新; 柯文哲; 虞希禹; 黃書健; 王主科; 吳美環; 王水深; LIN, M. H.; CHOU, NAI-KUAN; CHEN, YIH-SHARNG; CHI, NAI-HSIN; KO, WEN-JE; YU, HSI-YU; HUANG, SHU-CHIEN; WANG, JOU-KOU; WU, MEI-HWAN; WANG, SHOEI-SHEN |
| 臺大學術典藏 |
2010 |
Outcome in children bridged and nonbridged to cardiac transplantation
|
Lin M.H.;Chou N.K.;Yih-Sharng Chen;Chi N.H.;Ko W.J.;Yu H.Y.;Huang S.C.;Wu N.T.;Wang J.K.;Wu M.H.;Wang S.S.; Lin M.H.; Chou N.K.; YIH-SHARNG CHEN; Chi N.H.; Ko W.J.; Yu H.Y.; Huang S.C.; Wu N.T.; Wang J.K.; Wu M.H.; Wang S.S. |
| 臺大學術典藏 |
2020-03-09T07:30:48Z |
Outcome in children bridged and nonbridged to cardiac transplantation
|
Lin M.H.;Nai-Kuan Chou;Chen Y.S.;Chi N.H.;Ko W.J.;Yu H.Y.;Huang S.C.;Wu N.T.;Wang J.K.;Wu M.H.;Wang S.S.; Lin M.H.; NAI-KUAN CHOU; Chen Y.S.; Chi N.H.; Ko W.J.; Yu H.Y.; Huang S.C.; Wu N.T.; Wang J.K.; Wu M.H.; Wang S.S. |
| 臺大學術典藏 |
2021-05-06T02:22:05Z |
Outcome in children bridged and nonbridged to cardiac transplantation
|
Lin M.H.; Chou N.K.; Chen Y.S.; Chi N.H.; Ko W.J.; HSI-YU YU; Huang S.C.; Wu N.T.; Wang J.K.; Wu M.H.; Wang S.S. |
| 國立臺灣大學 |
2010-01 |
Outcome Knowledge, Experience and Judge’s Evaluation of Audit Quality.
|
Duh, Rong-Ruey; Lin, Hsiao-Lun |
| 中國醫藥大學 |
2012-04 |
Outcome Measurement of Overactive Bladder
|
連啟舜(Chi-Shun Lien);鄒頡龍(Chieh-Lung Chou)* |
| 國立成功大學 |
2014-12 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Chen, Chi-An; Lin, Hao; Weng, Chia-Sui; Wen, Kuo-Chang; Lu, Chien-Hsing; Chou, Hung-Hsueh; Huang, Yu-Fang; Kang, Chieh-Yi; Ho, Chih-Ming; Yu, Mu-Hsien; Chou, Cheng-Yang |
| 臺大學術典藏 |
2018-09-10T15:02:48Z |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Chen, C.-A. and Lin, H. and Weng, C.-S. and Wen, K.-C. and Lu, C.-H. and Chou, H.-H. and Huang, Y.-F. and Kang, C.-Y. and Ho, C.-M. and Yu, M.-H. and Chou, C.-Y.; CHI-AN CHEN |
| 臺大學術典藏 |
2014 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Lin H.; Weng C.-S.; Wen K.-C.; Lu C.-H.; Chou H.-H.; Huang Y.-F.; Kang C.-Y.; Ho C.-M.; Yu M.-H.; Chou C.-Y.; CHI-AN CHEN |
| 國立成功大學 |
2002-04 |
Outcome of acid ingestion related aspiration pneumonia
|
Tseng, Yau-Lin; Wu, Ming-Ho; Lin, Mu-Yen; Lai, Wu-Wei |
| 國立成功大學 |
2011 |
Outcome of Acute Ischemic Stroke in Very Elderly Patients: Is Intravenous Thrombolysis Beneficial?
|
Sung, Pi-Shan; Chen, Chih-Hung; Hsieh, Han-Chieh; Fang, Chen-Wen; Hsieh, Cheng-Yang; Sun, Yuan-Ting; Hwang, Wen-Juh |
| 臺大學術典藏 |
2020-09-29T16:41:33Z |
Outcome of acute leukemia patients with central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation
|
Kuo, Wen-Han; Chen, Yu-Hsuan; Kuo, Sung-Hsin; Tang, Jih-Luh; Liao, Xiu-Wen; Tsai, Cheng-Hong |
| 臺大學術典藏 |
2018 |
Outcome of acute leukemia patients with central nervous system (CNS) involvement treated with total body or CNS irradiation before transplantation
|
Liao, Xiu-Wen; Kuo, Sung-Hsin; Tang, Jih-Luh; Kuo, Wen-Han; CHENG-HONG TSAI; Chen, Yu-Hsuan |
| 臺大學術典藏 |
2022-08-19T00:21:08Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; CHIUN HSU; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.; CHIH-HUNG HSU; Yu C.-J.; Chang Y.-C.; Hsu C.; Yang C.-H.;Yang P.-C.;Cheng A.-L.;Lin C.-C.;CHIH-HUNG HSU;Yu C.-J.;Chang Y.-C.;Hsu C.;Lin Z.-Z.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Yang C.-H.;Yang P.-C;Cheng A.-L;Chia-Chi Lin;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C; Chang Y.-C; Yu C.-J; Hsu C.-H; Chia-Chi Lin; Cheng A.-L; Yang P.-C; Yang C.-H. |
| 臺大學術典藏 |
2008 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C |
| 臺大學術典藏 |
2020-04-10T12:51:23Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Yang C.-H.; Yang P.-C.; Cheng A.-L.; Lin C.-C.; Hsu C.-H.; Yu C.-J.; Chang Y.-C.; Chiun Hsu; Lin Z.-Z. |
| 臺大學術典藏 |
2021-03-19T06:57:53Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; YEUN-CHUNG CHANG; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:29Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; ANN-LII CHENG; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2020-12-02T02:34:36Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; PAN-CHYR YANG; Yang C.-H. |
| 臺大學術典藏 |
2022-06-10T06:11:16Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-06-27T07:06:22Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Chia-Chi Lin; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
